An Open Randomized Multicentre Phase 2 Trial to Assess the Safety of DAV132 and Its Efficacy to Protect Gut Microbiota Diversity in Hospitalized Patients Treated with Fluoroquinolones
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined